Using Resources for Scientific-Driven Pharmacovigilance Giovanni Furlan Current Opinion 13 December 2012 Pages: 615 - 622
Do Package Inserts Reflect Symptoms Experienced in Practice? Jennifer S. HaasMary AmatoDavid W. Bates Short Communication 13 December 2012 Pages: 623 - 628
Safety Assessment of an Anti-Obesity Drug (Sibutramine) Jerzy E. TyczynskiDenise M. OleskeWon Chan Lee Original Research Article 13 December 2012 Pages: 629 - 644
Comparison of Three Pharmacovigilance Algorithms in the ICU Setting Sandra L. Kane-GillElizabeth A. ForsbergSteven M. Handler Original Research Article 13 December 2012 Pages: 645 - 653
Workshop- and Telephone-Based Interventions to Improve Adverse Drug Reaction Reporting Maria Teresa HerdeiroInĂªs Ribeiro-VazAdolfo Figueiras Original Research Article 13 December 2012 Pages: 655 - 665
Artesunate- and Amodiaquine-Associated Extrapyramidal Reactions John McEwen Original Research Article 13 December 2012 Pages: 667 - 675
Dose Omissions in Hospitalized Patients in a UK Hospital Jamie J. ColemanSarah E. McDowellRobin E. Ferner Original Research Article 13 December 2012 Pages: 677 - 683
Hearing Impairment Associated with Oral Terbinafine Use Joep H. G. SchollEugene P. van Puijenbroek Original Research Article 13 December 2012 Pages: 685 - 691
Drug-Induced Thrombocytopenia Zayd L. Al-NouriJames N. George Correspondence 13 December 2012 Pages: 693 - 694